Digital Content 
NEWS #PharmaBuzz
18 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/18/3190482/0/en/Eledon-Reports-Preliminary-Data-from-First-Six-Patients-with-Type-1-Diabetes-Treated-with-Tegoprubart-as-the-Core-Immunosuppressant-Following-Islet-Transplantation-in-Investigator-.html
14 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/14/3188645/0/en/Eledon-Pharmaceuticals-Announces-Recent-Business-Highlights-and-Third-Quarter-2025-Financial-Results.html
06 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/06/3183316/0/en/Eledon-Presents-Phase-2-BESTOW-Trial-Results-for-Tegoprubart-for-the-Prevention-of-Rejection-in-Kidney-Transplantation-at-the-American-Society-of-Nephrology-s-Kidney-Week-2025-Annu.html
30 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/30/3158574/23161/en/STRATA-Skin-Sciences-Receives-Continued-Validation-for-its-Personalized-Approach-with-New-Published-Study-Highlighting-XTRAC-Excimer-Laser-Treatment-Combined-with-a-Topical-Drug-in.html
18 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/18/3152357/0/en/Lipella-Pharmaceuticals-Announces-Positive-Final-Results-from-Phase-2a-Study-of-LP-10-in-Oral-Lichen-Planus.html
30 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/veloxis-pharmaceuticals-to-present-at-2025-world-transplant-congress-302516650.html
Share 